Hubert Department of Global Health, School of Medicine, Emory University, Atlanta, Georgia.
Department of Epidemiology, Rollins School of Public Health, School of Medicine, Emory University, Atlanta, Georgia.
J Infect Dis. 2019 Jul 31;220(5):730-734. doi: 10.1093/infdis/jiy682.
Human papillomavirus (HPV) vaccination is suboptimally used in the United States. Vaccination before the 13th birthday is recommended by the Advisory Committee on Immunization Practices and vaccination before the 15th birthday requires only 2 doses. We estimated the proportion of adolescents up to date for HPV vaccine using provider-verified vaccination data from the 2016 National Immunization Survey-Teen. Only 16% of US adolescents completed HPV vaccination before turning 13, and 35% completed HPV vaccination before turning 15. With sexual activity initiation increasing throughout adolescence and higher immunogenicity for younger vaccinees, vaccination before the 13th birthday can provide better protection against HPV-related cancers.
人乳头瘤病毒（HPV）疫苗在美国的接种情况并不理想。免疫实践咨询委员会建议在 13 岁生日之前接种疫苗，而在 15 岁生日之前只需要接种 2 剂。我们使用 2016 年国家免疫调查-青少年的数据，根据提供者验证的疫苗接种数据来估计青少年 HPV 疫苗的接种比例。只有 16%的美国青少年在 13 岁之前完成 HPV 疫苗接种，35%的青少年在 15 岁之前完成 HPV 疫苗接种。随着青春期开始性行为的增加，以及对年轻疫苗接种者更高的免疫原性，在 13 岁生日之前接种疫苗可以更好地预防 HPV 相关癌症。
